Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott Sells In Vitro, Point-Of-Care Diagnostics Businesses To General Electric For $8 Billion

This article was originally published in The Pink Sheet Daily

Executive Summary

Deal continues Abbott’s strategy over the last few years of becoming more focused on its pharmaceuticals business.

You may also be interested in...

Abbott Finds Lipid Lowering Partner With Kos Acquisition

Candidates would be competitors to Pfizer's Lipitor/torcetrapib combination.

Hospira Spins Off With $4.2 Bil. Market Cap; Abbokinase Stays With Abbott

Abbott initially pegged Abbokinase as one of its hospital-based products to be divested with Hospira, but later decided the drug had a more strategic fit with the rest of its Rx portfolio.

Hologic Continues 2021 Spending Spree With $795M Acquisition Of Mobidiag

Mobidiag develops molecular diagnostic tests and instrumentation that will expand Hologic’s acute care testing capabilities.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts